David McClung - 14 Apr 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: Chief Financial Officer
Signature: /s/ David McClung
Issuer symbol: BCDA
Transactions as of: 14 Apr 2022
Net transactions value: $0
Form type: 4
Filing time: 18 Apr 2022, 21:17:31 UTC
Previous filing: 11 Jun 2021
Next filing: 07 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA	Common Stock	Award	$0	+50,345	+108%	$0.000000	97,150	14 Apr 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA	Stock Option (right to buy)	Award	$0	+60,000		$0.000000	60,000	14 Apr 2022	Common Stock	60,000	$1.49	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
F2	The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.